CYP2C9 c.976_977inv ;(p.E326S)

Variant ID: 10-96740954-GA-TC

NM_000771.3(CYP2C9):c.976_977inv;(p.E326S)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Genetic and Non-Genetic Factors Impact on INR Normalization in Preprocedural Warfarin Management.

Pharmacogenomics And Personalized Medicine
Eljilany, Islam I; Elarref, Mohamed M; Shallik, Nabil N; Elzouki, Abdel-Naser AN; Bader, Loulia L; El-Bardissy, Ahmed A; Abdelsamad, Osama O; Al-Badriyeh, Daoud D; Cavallari, Larisa H LH; Elewa, Hazem H
Publication Date: 2021

Variant appearance in text: CYP2C9: e326S
PubMed Link: 34483679
Variant Present in the following documents:
  • pgpm-14-1069.pdf
View BVdb publication page



Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Chest
You, John J JJ; Singer, Daniel E DE; Howard, Patricia A PA; Lane, Deirdre A DA; Eckman, Mark H MH; Fang, Margaret C MC; Hylek, Elaine M EM; Schulman, Sam S; Go, Alan S AS; Hughes, Michael M; Spencer, Frederick A FA; Manning, Warren J WJ; Halperin, Jonathan L JL; Lip, Gregory Y H GYH
Publication Date: 2012-02

Variant appearance in text: CYP2C9: e326S
PubMed Link: 22315271
Variant Present in the following documents:
  • Main text
View BVdb publication page